Genesis Financial Group LLC acquired a new stake in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 28,363 shares of the semiconductor company’s stock, valued at approximately $4,855,000. Lam Research accounts for about 2.8% of Genesis Financial Group LLC’s holdings, making the stock its 9th biggest position.
Other hedge funds have also recently modified their holdings of the company. Abound Wealth Management lifted its position in Lam Research by 6.9% during the 4th quarter. Abound Wealth Management now owns 931 shares of the semiconductor company’s stock valued at $159,000 after acquiring an additional 60 shares during the period. McLean Asset Management Corp boosted its stake in Lam Research by 1.3% during the fourth quarter. McLean Asset Management Corp now owns 5,099 shares of the semiconductor company’s stock worth $873,000 after acquiring an additional 65 shares in the last quarter. Catalyst Private Wealth LLC grew its holdings in Lam Research by 4.2% in the fourth quarter. Catalyst Private Wealth LLC now owns 1,658 shares of the semiconductor company’s stock worth $284,000 after purchasing an additional 67 shares during the period. Gryphon Financial Partners LLC grew its holdings in Lam Research by 4.0% in the fourth quarter. Gryphon Financial Partners LLC now owns 1,752 shares of the semiconductor company’s stock worth $300,000 after purchasing an additional 68 shares during the period. Finally, Gilliland Jeter Wealth Management LLC increased its stake in shares of Lam Research by 0.3% during the third quarter. Gilliland Jeter Wealth Management LLC now owns 26,501 shares of the semiconductor company’s stock valued at $3,548,000 after purchasing an additional 69 shares in the last quarter. Institutional investors own 84.61% of the company’s stock.
Lam Research Price Performance
Shares of LRCX opened at $218.44 on Friday. The company has a market capitalization of $272.78 billion, a P/E ratio of 44.76, a price-to-earnings-growth ratio of 2.39 and a beta of 1.78. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37. The firm has a 50 day moving average of $227.01 and a 200 day moving average of $184.19. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $256.68.
Lam Research Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be given a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, March 4th. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. Lam Research’s dividend payout ratio (DPR) is 21.31%.
Insider Buying and Selling
In other news, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the sale, the director owned 253,705 shares of the company’s stock, valued at $57,235,848. This trade represents a 12.12% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Ava Harter sold 1,500 shares of Lam Research stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $222.66, for a total transaction of $333,990.00. Following the completion of the sale, the insider owned 53,205 shares of the company’s stock, valued at $11,846,625.30. This represents a 2.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 130,886 shares of company stock worth $29,658,802. 0.31% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
A number of analysts have recently commented on the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $320.00 price target (up from $265.00) on shares of Lam Research in a research report on Thursday, January 29th. UBS Group set a $300.00 price objective on Lam Research in a research report on Thursday, January 29th. B. Riley Financial reiterated a “buy” rating on shares of Lam Research in a research note on Thursday, January 15th. Evercore set a $275.00 target price on Lam Research in a report on Thursday, January 29th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on Lam Research from $260.00 to $290.00 and gave the stock a “buy” rating in a research note on Thursday, January 29th. One analyst has rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $245.35.
View Our Latest Report on LRCX
Key Headlines Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: AI-driven demand positions Lam as a “pick-and-shovel” beneficiary — analysts note semiconductor equipment names like LRCX are surging as AI chip capex lifts long-term revenue potential. 2 AI Pick-and-Shovel Stocks Poised to Be the Next NVIDIA
- Positive Sentiment: Bullish fundamental coverage — Seeking Alpha highlights Lam’s strong margins, improved operating efficiency and positioning as a critical etch-equipment supplier to foundries, supporting longer-term growth expectations. Lam Research: Poised For Growth, Looking Past Short-Term Turbulence
- Positive Sentiment: Price-target lift: New Street Research raised its target to $235 (from $140) — signaling higher valuation potential even while keeping a neutral rating, which can underpin upside expectations. New Street adjusts price target on Lam Research to $235
- Neutral Sentiment: Corporate calendar: Lam set its March-quarter earnings conference call for April 22 — a near-term event that could drive volatility depending on guidance and commentary. Lam Research Corporation Announces March Quarter Financial Conference Call
- Neutral Sentiment: Notable investor moves: Coverage notes Ray Dalio’s Bridgewater trimmed its Lam stake — signals attention from large holders but not necessarily a directional verdict. Lam Research Corporation (LRCX): Billionaire Ray Dalio Trims Stake in Chip Stock
- Negative Sentiment: Analyst downgrade: Erste Group cut LRCX from “buy” to “hold,” adding near-term selling pressure as momentum investors react. Finviz: Analyst downgrade
- Negative Sentiment: Regulatory risk: U.S. lawmakers unveiled draft legislation to tighten exports of chipmaking tools to China — broader restrictions would reduce addressable markets for equipment suppliers and increase geopolitical uncertainty. US Lawmakers Propose Crackdown on Chip Tool Sales to China
About Lam Research
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
